help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-0036
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yarram, S. J.
Right arrow Articles by Mansell, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yarram, S. J.
Right arrow Articles by Mansell, J. P.
Endocrinology Vol. 144, No. 8 3555-3564
Copyright © 2003 by The Endocrine Society

Luteinizing Hormone Receptor Knockout (LuRKO) Mice and Transgenic Human Chorionic Gonadotropin (hCG)-Overexpressing Mice (hCG {alpha}ß+) Have Bone Phenotypes

S. J. Yarram, M. J. Perry, T. J. Christopher, K. Westby, N. L. Brown, T. Lamminen, S. B. Rulli, F.-P. Zhang, I. Huhtaniemi, J. R. Sandy and J. P. Mansell

Department of Oral & Dental Sciences (S.J.Y., K.W., N.L.B., J.R.S., J.P.M.), Division of Child Dental Health, University of Bristol Dental School, Bristol BS1 2LY, United Kingdom; Department of Orthopaedics (M.J.P., T.J.C.), University of Bristol, Bristol BS2 8EJ, United Kingdom; and Department of Physiology (T.L., S.B.R., F.-P.Z., I.H.), University of Turku, FIN-20520 Turku, Finland

Address all correspondence and requests for reprints to: Dr. Jason P. Mansell, Division Child Dental Health, University of Bristol Dental School, Lower Maudlin Street, Bristol BS1 2LY, United Kingdom. E-mail: j.p.mansell{at}bris.ac.uk.

Considerable attention has been paid to the role of sex steroids during periods of major skeletal turnover, but the interaction of the gonadotropic hormones, which include LH, FSH, and human chorionic gonadotropin (hCG), within bone tissue have been overlooked. The question is pertinent due to the recent detection of extragonadal expression of gonadotropin receptors. Western blotting, immunolocalization, and RT-PCR supported the presence of osteoblast LH receptors. However, osteoblast cells failed to bind [125I]hCG and treatment with hCG failed to generate either cAMP or phosphorylated ERK 1/2. Bone mineral density (BMD) and bone histomorphometry were examined in the following models: 1) LH receptor null mutant (LuRKO) mice; 2) transgenic mice overexpressing hCG (hCG {alpha}ß+); and 3) ovariectomized (OVX) hCG {alpha}ß+ model. Male LuRKO mice showed a decrease in BMD after 5 months, apparently secondary to suppressed gonadal steroid production. Similarly, 9- to 10-wk-old female LuRKO mice exhibited decreases in histomorphometric parameters tested. The data indicate that loss of LH signaling results in a reduction in bone formation or an increase in bone resorption. By contrast, there were significant increases in BMD and histomorphometric indices for female, but not male, hCG {alpha}ß+ mice, indicating that chronic exposure to hCG results in bone formation or a decrease in bone resorption. However, OVX of the hCG {alpha}ß+ mice resulted in a significant reduction in BMD comparable to OVX WT controls. Although gonadotropin levels are tightly linked to sex steroid titers, it appears that their effects on the skeleton are indirect.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. E. Stevenson, B. A. J. Evans, E. F. Gevers, C. Elford, R. W. J. McLeod, M. J. Perry, M. M. El-Kasti, K. T. Coschigano, J. J. Kopchick, S. L. Evans, et al.
Does adiposity status influence femoral cortical strength in rodent models of growth hormone deficiency?
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E147 - E156.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
E. Dos Santos, M.-N. Dieudonne, M.-C. Leneveu, R. Pecquery, V. Serazin, and Y. Giudicelli
In vitro effects of chorionic gonadotropin hormone on human adipose development
J. Endocrinol., August 1, 2007; 194(2): 313 - 325.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
T R. Kumar
What have we learned about gonadotropin function from gonadotropin subunit and receptor knockout mice?
Reproduction, September 1, 2005; 130(3): 293 - 302.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. L. Bowen, G. Verdile, T. Liu, A. F. Parlow, G. Perry, M. A. Smith, R. N. Martins, and C. S. Atwood
Luteinizing Hormone, a Reproductive Regulator That Modulates the Processing of Amyloid-{beta} Precursor Protein and Amyloid-{beta} Deposition
J. Biol. Chem., May 7, 2004; 279(19): 20539 - 20545.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society